Crescent Biopharma Inc
F:C68
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Crescent Biopharma Inc
F:C68
|
US |
|
Aeris Environmental Ltd
ASX:AEI
|
AU |
|
I
|
Idico Corporation JSC
VN:IDC
|
VN |
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
UK |
|
O
|
Ocean Bio-Chem Inc
F:OBC
|
US |
|
H
|
Helix Resources Ltd
ASX:HLX
|
AU |
|
Aerkomm Inc
OTC:AKOM
|
US |
|
R
|
Redan SA
WSE:RDN
|
PL |
|
C
|
Curvebeam AI Ltd
ASX:CVB
|
US |
|
Comfort Systems USA Inc
NYSE:FIX
|
US |
Wall Street
Price Targets
C68 Price Targets Summary
Crescent Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
C68
is 23.87 EUR
with a low forecast of 17.73 EUR and a high forecast of 29.32 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is C68's stock price target?
Price Target
23.87
EUR
According to Wall Street analysts, the average 1-year price target for
C68
is 23.87 EUR
with a low forecast of 17.73 EUR and a high forecast of 29.32 EUR.
What is Crescent Biopharma Inc's Revenue forecast?
Projected CAGR
-14%
For the last 13 years the
compound annual growth rate for
Crescent Biopharma Inc's revenue is
-3%.
The projected
CAGR
for the next 3 years is
-14%.
